KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Sales (2016 - 2025)

Historic Return on Sales for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 0.14%.

  • Amgen's Return on Sales rose 700.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.21%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.21% for FY2025, which is 900.0% up from last year.
  • Per Amgen's latest filing, its Return on Sales stood at 0.14% for Q4 2025, which was up 700.0% from 0.34% recorded in Q3 2025.
  • Amgen's 5-year Return on Sales high stood at 0.47% for Q1 2023, and its period low was 0.02% during Q1 2024.
  • Moreover, its 5-year median value for Return on Sales was 0.22% (2025), whereas its average is 0.21%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 2300bps in 2023, then tumbled by -4800bps in 2024.
  • Over the past 5 years, Amgen's Return on Sales (Quarter) stood at 0.28% in 2021, then fell by -15bps to 0.24% in 2022, then tumbled by -60bps to 0.09% in 2023, then fell by -26bps to 0.07% in 2024, then skyrocketed by 96bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q4 2025, 0.34% for Q3 2025, and 0.16% during Q2 2025.